Osteosarcoma and chondrosarcoma compose most of the primary malignancies of the shoulder. The literature lacks site-specific comparative analyses of these 2 major shoulder sarcomas. The purposes of this study were to describe the different characteristics of the 2 major sarcomas near the glenohumeral joint, examine differences in treatment outcomes, and evaluate the functional outcomes of limb salvage surgery.
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Osteosarcoma and chondrosarcoma compose most of the primary malignancies of the shoulder. The literature lacks site-specific comparative analyses of these 2 major shoulder sarcomas. The purposes of this study were to describe the different characteristics of the 2 major sarcomas near the glenohumeral joint, examine differences in treatment outcomes, and evaluate the functional outcomes of limb salvage surgery.
Thirty-two patients with osteosarcoma or chondrosarcoma who underwent a wide resection including the glenohumeral joint were enrolled in this study. The characteristics of tumor development and treatment, oncologic and functional outcomes, and factors affecting outcomes were compared between groups and with the literature. The results showed shoulder osteosarcoma developing similarly to the literature reports, whereas chondrosarcoma tended to be of a high histologic grade. Nonetheless, the osteosarcoma group had a poorer overall 5-year survival rate (53.0%) than the chondrosarcoma group (85.7%) or those in previous reports. The osteosarcoma group had a tendency toward a worse 5-year metastasis-free survival rate than the chondrosarcoma group (35.4% vs 75.0%, respectively), although the 5-year local recurrence-free survival rate was not significantly different between the 2 groups (75.0% vs 87.5%, respectively). Histologic grade, surgical stage, and chemotherapy affected the oncologic outcomes in univariate analysis, although not a single factor was independent in multivariate analysis. The functional outcomes were not significantly affected by clinical characteristics or surgical methods in patients who had undergone a wide resection including the glenohumeral joint.
O steosarcoma and chondrosarcoma are the most common and second most common primary bone malignancies, respectively. 1, 2 Once a curative treatment is planned, the 2 sarcomas must be surgically removed, and the contemporary literature reports similar long-term survival rates for localized osteosarcoma and chondrosarcoma (approximately 70%). [3] [4] [5] [6] However, differences in many biologic and clinical aspects exist between the 2 sarcomas, such as location and chemotherapeutic response.
Besides the histologic diagnosis, the characteristics and treatment outcomes of a given tumor may vary, along with the location of the tumor. Reports exist that a pelvic chondrosarcoma had a worse prognosis than the same tumor in other regions. 7, 8 Although the prognostic effect of tumor location is often attributed to the anatomic complexity of the region, the developing pattern of a given tumor may differ in a specific site and thus affect the treatment outcome.
In the shoulder girdle, osteosarcoma and chondrosarcoma compose most of the primary malignancies. 9 The shoulder is a common site for the development of primary bone malignancy because the humerus is the third most common site of primary bone malignancy. 10 The shoulder is the most widely mobile joint, puts the hand in the right position, and contains many vital structures, such as the brachial plexus and axillary vessels, which determine the function, and sometimes the existence itself, of the whole upper extremity. This makes it difficult to resect a tumor with a wide margin in the shoulder girdle. However, regional complexity for surgery may not be the only factor that makes treatment outcomes different in the shoulder. A tumor in the shoulder may have characteristics that differentiate it from the same tumor in other regions, although this is not clearly delineated for osteosarcoma and chondrosarcoma.
The purposes of this study were to describe the different characteristics of the 2 major sarcomas near the glenohumeral joint, examine differences in treatment outcomes, and evaluate the functional outcomes of limb salvage surgery.
Materials and Methods

Patient Enrollment
Sixty-five consecutive patients who were diagnosed with a malignant tumor around the shoulder girdle at a single institution were reviewed. Among them, 32 patients with osteosarcoma or chondrosarcoma had undergone a wide resection including the glenohumeral joint and were enrolled in the study. Data were collected with the approval of the institutional review board. Mean follow-up was 61.7 months (range, 4-218 months). The 33 excluded patients had 26 primary sarcomas and 7 metastases from other primary cancers. Among the 26 excluded primary sarcomas, 9 patients had primary sarcomas other than osteosarcoma or chondrosarcoma, and the remaining 17 had osteosarcomas or chondrosarcomas that included 5 with distant metastasis at diagnosis (4 osteosarcoma, 1 chondrosarcoma), 2 who had not undergone surgery (2 osteosarcoma), and 10 who had undergone a wide resection saving the glenohumeral joint (5 osteosarcoma, 5 chondrosarcoma).
Diagnosis and Surgery
The preoperative diagnosis was made by biopsy, which was performed when radiographs and magnetic resonance imaging suggested a malignancy. When the patient had undergone a previous unplanned surgery, the pathology slide was examined for the diagnosis. Distant metastasis was surveyed by chest computed tomography and bone scan. After confirming that the tumor was malignant and no metastasis existed, a wide excision or an amputation with curative intent was performed. Resection included the glenohumeral joint in all cases, either intra-articularly or extra-articularly, for an adequate safety margin. In cases in which the defect was reconstructed, the reconstruction was performed with a tumor prosthesis, cementmetal composite, or arthrodesis using a vascularized fibula graft. The final pathology report confirmed that the tumor was either osteosarcoma or chondrosarcoma.
Characteristics and Outcomes
Medical records and imaging studies were reviewed to investigate the differences in patient characteristics, oncologic outcomes, functional outcomes, and factors affecting the outcomes between the osteosarcoma and chondrosarcoma groups. Patient characteristics were classified into 2 groups: the developing pattern and the treatment. The developing patterns of the 2 sarcomas were age at diagnosis, sex, tumor location (humerus or scapula), presentation (fresh [ie, no history of unplanned excision of the lesion] or with previous unplanned surgery), tumor size in the longest diameter, histologic grade according to the classification of Fédération Nationale des Centres de Lutte Contre le Cancer (grade 15low; grade 2 or 35high), 11 and surgical stage according to the Musculoskeletal Tumor Society (MSTS).
12 Treatment characteristics were surgery type (limb salvage or amputation), resection margin status (clear or involved), and chemotherapy. No patient underwent radiotherapy.
For comparison of oncologic outcomes, overall survival, local recurrence, and distant metastasis were evaluated. To discern whether patient characteristics other than diagnosis affected oncologic outcomes, all 32 patients were analyzed for overall survival. The functional outcomes of the patients who underwent limb salvage surgery were analyzed by the MSTS functional score 13 regarding diagnosis, age at diagnosis, sex, tumor location, tumor size, surgical stage, resection type according to the classification of Malawer et al, 14 and reconstruction type (prosthesis, composite, arthrodesis, or no reconstruction).
Statistical Analysis
The chi-square test was used for categorical data (sex, presentation, location, histologic grade, surgical stage and type, margin status, and chemotherapy), and the Mann-Whitney U test was used for continuous data (age and size). To analyze oncologic outcomes, the Kaplan-Meier method was used, and the comparison between osteosarcoma and chondrosarcoma was made by log-rank test. Factors affecting the outcomes were analyzed by univariate log-rank method and multivariate Cox proportional hazards regression model. For the analysis of functional outcomes, the 1-way analysis of variance test was performed. Null hypotheses of no difference were rejected if P values were less than .05.
results
Characteristics of Osteosarcoma and Chondrosarcoma in the Shoulder
The characteristics of the 32 patients are summarized in Tables 1 and 2 . The osteosarcoma and chondrosarcoma groups were significantly different in age at diagnosis, tumor location, and histologic grade; the osteosarcoma patients were younger, had the tumor exclusively in humerus, and had higher grade tumors. Sex, previous unplanned excision, tumor size, and surgical stage were not significantly different between the 2 groups. Regarding treatment, surgery type and margin status were not significantly different between the 2 groups, but chemotherapy was performed for osteosarcoma more often than for chondrosarcoma.
Oncologic Outcomes
The Figure and Table 3 show the oncologic outcomes of patients with osteosarcoma and chondrosarcoma. Overall 5-year survival rate was 53.0% in the osteosarcoma group and 85.7% in the chondrosarcoma group. The tendency existed for the osteosarcoma group to suffer a worse 5-year metastasis-free survival rate than the chondrosarcoma group (35.4% vs 75.0%), although this was not statistically significant. The local recurrence rate was not significantly different between the 2 groups.
Factors Affecting Outcomes
The results of univariate and multivariate analyses for factors affecting the outcomes are summarized in Table 4 . Surgical stage and chemotherapy significantly affected survival in univariate analysis, and histologic grade was also a possible risk factor (P5.05). Combined with the comparison of tumor characteristics, those with higher surgical stage showed significantly worse overall survival, although the stage was not significantly different between the osteosarcoma and chondrosarcoma groups. Chemotherapy was performed significantly more often for the osteosarcoma group, and those who underwent chemotherapy had significantly worse overall survival. The histologic grade was higher in the osteosarcoma group, and those with a high histologic grade had poorer overall survival. Whether the tumor was located in the humerus or scapula was not significant for overall survival, although it was significantly different between the osteosarcoma and chondrosarcoma groups. Age, sex, previous unplanned surgery, tumor size, surgery type, and margin status did not differ significantly between the osteosarcoma and chondrosarcoma groups and were not associated significantly with overall survival. In multivariate analysis, no single factor was associated with overall survival, leading to the interpretation that no factor independently affected outcomes in either group.
Functional Outcomes
At final follow-up, mean MSTS functional score was 19.9 (range, . The score was not significantly affected by diagnosis, age, sex, tumor location, tumor size, surgical stage, resection type, or reconstruction type (Table 5) .
discussion
Site-specific analysis shows that a single tumor may behave differently according to the location. Pelvic osteosarcoma reportedly has a poorer prognosis than the same tumor in the other parts of the body. 15, 16 The purposes of this study were to investigate the site-specific properties of osteosarcoma and chondrosarcoma in the shoulder and to evaluate whether the properties affected the outcomes, comparing the 2 major sarcomas with each other and with the literature.
The study's results revealed that osteosarcoma and chondrosarcoma near the glenohumeral joint had different developing patterns, with some differences from the literature. Shoulder osteosarcoma developed in younger patients than did shoulder chondrosarcoma. This age distribution was similar to the overall tendency in previous reports; osteosarcoma has its first incidence peak during adolescence and the second peak in older adulthood, whereas chondrosarcoma peaks around the fifth decade. 4, 5 The literature varies about the prognostic effect of age at diagnosis for osteosarcoma and chondrosarcoma. 7, 17 In the current analysis, age was not associated with outcome.
Regarding the location within the shoulder, osteosarcoma developed exclusively in the humerus in the study population. In contrast, 3 of 10 chondrosarcomas developed in the scapula. Osteosarcoma is known to develop more frequently in long bones; chondrosarcoma develops most commonly in the pelvis, followed by the long bones. 8, 18 In the humerus, the most common bone sarcoma is osteosarcoma followed by chondrosarcoma; in the scapula, it is chondrosarcoma followed by osteosarcoma. 19, 20 The current findings reflect these previous reports. The scapula is thought to be better for surgical treatment than the proximal humerus due to its relative anatomical simplicity. 21 However, the humeral/scapular location had no significant effect on overall survival in the current results, including tumors needing a wide excision including the glenohumeral joint.
Another difference of the developing patterns of osteosarcoma and chondrosarcoma in the shoulder was the histologic grade. Histologic grade is reported to be 
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one of the most important prognostic factors and the best indicator of metastatic risk in sarcomas. 22, 23 The literature gives a relatively even grade distribution for osteosarcoma, with low-grade osteosarcomas composing 10% of all cases. 24 For chondrosarcoma, variable reports exist on the grade distribution, although most found a greater proportion of low-grade than high-grade chondrosarcoma. [25] [26] [27] In the current results, the histologic grade of osteosarcoma was significantly higher than that of chondrosarcoma, which was similar to previous reports. 2, 5, 24 However, chondrosarcoma had a relatively higher proportion of high grade (50%) compared with previous reports, 2, 5, 24 although it was lower than osteosarcoma. The histologic grade appeared to affect survival (P5.05), and the osteosarcoma group showed significantly poorer overall survival, with a nonsignificant tendency to higher metastatic potential.
Other characteristics of developing patterns-sex, previous unplanned excision, tumor size, and surgical stage-were not significantly different between the 2 groups and had no significant effect on overall survival, except for surgical stage. In multivariate analyses, no single factor was significantly associated with overall survival, including histologic grade and surgical stage. This suggests that no independent factor exists and that different characteristics affect the overall survival of shoulder osteosarcoma and chondrosarcoma in a complex fashion. Therefore, the locational effect of the shoulder may be important for outcomes.
Regarding treatment, surgery type (limb salvage vs amputation) and surgical margin status showed no significant difference between the osteosarcoma and chondrosarcoma groups, suggesting that the surgical treatment was equivalent for the 2 groups. No patient underwent radiotherapy, and chemotherapy was performed almost exclusively in patients with osteosarcoma. Chemotherapy is an adjuvant modality that improves the long-term survival of sarcoma patients. 18, 28 However, it has been proven to be effective for certain types of sarcoma and not for the others. Contemporary treatment principles include chemotherapy for osteosarcoma, but generally not for the chondrosarcoma. 18, 29 In the current study, the only chondrosarcoma for which chemotherapy was performed was a mesenchymal type, which is reported to be effective with chemotherapy. 29 Therefore, it is thought that a standard textbook treatment was performed for the primary tumor in both groups. This was proven by the fact that the 2 groups showed no significant difference in local recurrence-free survival rates. Although chemotherapy affected the overall survival negatively, it was thought to have little prognostic significance because it was performed almost exclusively for osteosarcoma, which showed much poorer overall survival rates. On the supposition that the treatment was equivalent for the 2 sarcomas, the tumor characteristics could be of more importance for the outcomes. The osteosarcoma group showed a significantly worse overall 5-year survival rate (53.0%) than did the chondrosarcoma group (85.7%). This differs somewhat from previous reports on the 2 sarcomas, in which osteosarcoma showed poorer survival rates despite developing patterns similar to those in the literature, and chondrosarcoma showed better survival rates despite a higher histologic grade than that in the literature. This could be attributed to histologic grade because osteosarcoma had the higher histologic grade and therefore had a worse overall survival than chondrosarcoma. However, considering that chondrosarcoma had a relatively better survival rate than in the literature, despite a relatively high proportion of high-grade chondrosarcomas, the histologic grade may not be the only factor responsible.
Another possible explanation would be that shoulder osteosarcoma is unique and prone to metastasizing despite having similar developing characteristics and treatment as the same tumor in other regions and therefore has a poorer overall survival. In the current results, osteosarcoma showed a tendency toward a poorer metastasis-free survival rate than chondrosarcoma. The literature gives similar 5-year metastasis-free survival rates for osteosarcoma and chondrosarcoma (approximately 60%-70%). 30, 31 The current results showed a 5-year metastasis-free survival rate of 35.4% for osteosarcoma. In contrast, the 5-year metastasis-free survival rate of chondrosarcoma was 75.0%, comparable with that in the literature. The metastasis-prone nature of shoulder osteosarcoma could be attributed to the concept that the shoulder is more axial than the knee, where osteosarcoma develops most commonly. Reports exist that the axial location negatively affects the outcomes of osteosarcoma, 32, 33 although whether an axial location is directly associated with metastasis is still unclear and should be further investigated. In this context, the results for chondrosarcoma may be considered acceptable because shoulder chondrosarcoma shows similar outcomes as in the literature because it develops most commonly in the pelvis, a similarly axial location.
The current analysis included the functional outcomes of limb salvage for osteosarcoma and chondrosarcoma in the shoulder. Mean MSTS score was 19.9, which was not better than that of previous reports. 9, 20, 34 The functional outcomes were not significantly affected by clinical characteristics or surgical methods. The reason for these functional results may be because the current study enrolled only patients who had undergone a wide resection including the glenohumeral joint. In previous reports, resections saving the glenohumeral joint, such as a resection confined to the scapular body, showed relatively better functional outcomes. 9, 34 Nonetheless, it is somewhat disappointing that reconstruction methods cannot make a difference in outcomes. This could be attributed to the difficulty in restoring the functional mechanism after wide excision including the glenohumeral joint. In practice, the rotator cuff, which is crucial for shoulder function, is often disrupted during wide excision. Even when the cuff is preserved, it is hard to achieve attachment to the prosthesis or bone graft secure enough to restore cuff muscle function. This may explain the better mean functional scores in patients undergoing no reconstruction in the current study and the superior outcomes of arthrodesis to those of preserving the articulation in previous reports. 9, 35 However, new reconstruction options are emerging, such as reverse total shoulder arthroplasty, which compensates the cuff defect to some degree, and thus chances may exist to improve the functional outcomes of the shoulder.
The small study population was the most substantial limitation of the current study. Factors affecting the outcomes were analyzed with all 32 cases taken together to determine whether patient characteristics other than diagnosis affected oncologic outcomes. The small study sample limited the separate analysis of osteosarcoma and chondrosarcoma groups, which may better reveal site-specific properties and prognostic factors. A larger multi-center study is necessary to confirm the current findings.
conclusion
In the current study, shoulder osteosarcoma developed similarly to that in the literature, whereas shoulder chondrosarcoma showed a relatively high proportion of high histologic grade. The shoulder may be a relatively axial location for osteosarcoma and a neutral location for chondrosarcoma, and this may account for the poor overall survival of shoulder osteosarcoma via higher metastatic potential. When a wide resection including the glenohumeral joint is performed, the functional outcomes are not significantly affected by clinical characteristics or surgical methods.
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